baber/WOPTO huggingface dataset:
Patent CA-2865426-A1 (CA)
Title: Oxygen-rich plasma generators for boosting internal combustion engines
Inventor: JONSON HUGH
IPC: F02M25/12
Filed: 2013-02-26
Abstract: Systems and methods for improving the efficiency and/or reducing emissions of an internal combustion engine are disclosed. The system may comprise a tank configured to store an aqueous solution consisting essentially of water and a predetermined quantity of electrolyte. The system may further comprise a cell configured for aiding in the electrolysis of the aqueous solution, the cell may comprise a plurality of plates arranged substantially parallel to one another and the plurality of plates may be spaced substantially equidistant from an adjacent one of the plurality of plates. In exemplary embodiments, at least one seal may be located between the plurality of plates to create a substantially air tight and substantially water tight seal between adjacent ones of the plurality of plates.
Patent CA-2867071-A1 (CA)
Inventor: ZSCHAECK THOMAS
IPC: A61N1/36
Filed: 2014-10-07
Abstract: The invention relates to a stimulation device (1) for the application of a transcutaneous electric stimulation stimulus onto the surface of a section of the human ear, which comprises a holding element (2) as well as at least one electrode (3, 4) which is arranged in a electrode carrier (5), wherein the holding element (2) comprises a linear guide (6), wherein a resting part (8) is arranged at the holding element (2), wherein the holding rod (7) comprises a first axis (A), wherein the holding rod (7) runs from a first position (P1), which adjoins to the linear guide (6), to a second position (P2), which adjoins to the electrode carrier (5), wherein the resting part (8) defines a first plane (EO) with a resting area (9) at the ear, on which area a second axis (B) is arranged perpendicular, wherein the first axis (A) and the second axis (B) span a middle plane (E1). To obtain a better stimulation by an improved placement of the electrodes on the skin surface of the ear the invention proposes that the holding rod (7) lies at the first position (P1) in the middle plane (E1), that the holding rod (7) departs from the middle plane (E1) from the run from the first position (P1) to the second position (P2) in a first rod section (10) until a reversal point (PU) and that the holding rod (7) moves to the middle plane (E1) from the run from the reversal point (PU) to the second position (P2) in a second rod section (11), so that it lies in the middle plane (E1) after arriving of the second position (P2).
Patent CA-2867766-A1 (CA)
Inventor: STAIB ARNULF
IPC: C12Q1/00
Filed: 2013-03-27
Abstract: The present invention relates to an electrode system for measuring the concentration of an analyte under in-vivo conditions, comprising an electrode with immobilized enzyme molecules and an improved diffusion barrier that controls diffusion of the analyte from body fluid surrounding the electrode system to the enzyme molecules.
Patent CA-2868506-A1 (CA)
Inventor: SINDEN JOHN
IPC: A61P9/00
Filed: 2013-04-03
Abstract: Cette invention se rapporte à des microparticules de cellules souches, leur utilisation et production, en particulier des microparticules de cellules souches neurales et leur utilisation en thérapie. La microparticule de cellules souches est typiquement un exosome ou microvésicule et peut être dérivée à partir d'une lignée de cellules souches neurales. La lignée de cellules souches neurales peut être une lignée de cellules souches à immortalisation conditionnelle telle que CTX0E03 (déposée auprès de l'ECACC avec le No d' Accès 04091601).
Patent CA-2868768-A1 (CA)
Inventor: DUGGAN MARK E
IPC: A61P9/00
Filed: 2013-03-12
Abstract: The invention relates to fluorinated compounds and their use in the field of pathological syndromes of the cardiovascular system. Novel fluorinated benzofuran derivatives of amiodarone and pharmaceutically acceptable salts or solvates thereof and their use for the treatment of arrhythmias are described.
Patent CA-2868955-A1 (CA)
Inventor: PEOTA ROBERT D
IPC: A47F7/14
Filed: 2014-10-27
Abstract: A sign stanchion includes a support frame having a first side and a second side. A plurality of substantially horizontal backer panels are mounted to the support frame, extend between the first and second sides of the support frame and are substantially vertically spaced apart from each other. At least one sign includes a main panel, a first tab coupled to a top of the main panel by a first bend and a second tab coupled to a bottom of the main panel by a second bend. The at least one sign is mounted to at least one of the plurality of backer panels by inserting one of the first tab and the second tab between two of the plurality of backer panels.
Patent CA-2873512-A1 (CA)
Title: Triazole compounds as antivirals
Inventor: BILOTTA JOSEPH ANTHONY
IPC: C07D403/12
Filed: 2013-07-03
Abstract: The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
Patent CA-2874780-A1 (CA)
Title: Polypeptides activant une inflammation et leurs utilisations
Inventor: GROS PHILIPPE
IPC: A61K39/395
Filed: 2013-05-27
Abstract: La présente technologie concerne l'utilisation de polypeptides activant une inflammation (ou leurs séquences codantes) pour cribler des agents utiles pour la prévention, le traitement et/ou le soulagement de symptômes associés à un trouble inflammatoire, pour identifier des individus susceptibles de développer une réponse inflammatoire exacerbée ainsi que pour déterminer si un régime thérapeutique est capable de prévenir, traiter ou soulager les symptômes associés à un trouble inflammatoire chez un individu. La présente technologie fournit également des méthodes pour prévenir, traiter et/ou soulager les symptômes associés à un état inflammatoire basé sur l'inhibition de l'expression ou de l'activité des cibles activant une inflammation.
Patent CA-2875426-A1 (CA)
Inventor: MICHEL FABRICE
IPC: G06T3/40
Filed: 2014-12-19
Abstract: The invention notably relates to computer-implemented method for resizing an image I. The method comprises the steps of: - providing the image / to resize; - providing an image significance by computing a significance of each pixel in the image to resize; - extracting an original spatial domain of the significance image; - providing a transformation T .theta., parameterized as an interpolating spline by a set of control points, from .OMEGA. to a resized spatial domain .OMEGA.; - subdividing .OMEGA. into cells, each cell being defined by a subset of control points of the set; - computing, for each cell, a weighted average of the significance of the pixels in the cell, the weighted average being computed using the interpolating spline; - deforming the cells of .OMEGA. by displacing one or more control points of the cells having a lesser weighted average; - computing the transformation T .theta. over a spatial domain of the image / using the displaced one or more control points; and - computing a resized image J by applying the computed transformation T .theta. to the spatial domain of the image / to resize.
Patent CA-2877232-A1 (CA)
Title: Prophylactic/therapeutic agent for influenza virus infection
Inventor: TANAKA TOHRU
IPC: A61P3/00
Filed: 2013-06-03
Abstract: Provided is a prophylactic/therapeutic agent for influenza viral infection that is effective not only before and at an early stage of infection with influenza virus but also at an intermediate or late stage of the infection and is highly safe for human bodies. A  prophylactic/therapeutic drug for influenza viral infection comprising, as active ingredients, 5-aminolevulinic acid (5-ALA), a derivative thereof or a salt of the 5-ALA or the derivative, and an iron compound is prepared. This prophylactic/therapeutic agent can be used for ameliorating (preventing) depression in food consumption, water consumption and body weight, for ameliorating (decreasing) increase in ketone body levels in blood that may otherwise cause ketosis, for ameliorating (preventing) depression in ATP levels in blood, or for ameliorating (increasing) a survival rate and depression in a body surface temperature.
Patent CA-2879363-A1 (CA)
Inventor: HENDRIX KAREN DENISE
IPC: G02B5/28
Filed: 2013-07-16
Abstract: An optical filter having a passband at least partially overlapping with a wavelength range of 800 nm to 1100 nm is provided. The optical filter includes a filter stack formed of hydrogenated silicon layers and lower-refractive index layers stacked in alternation. The hydrogenated silicon layers each have a refractive index of greater than 3 over the wavelength range of 800 nm to 1100 nm and an extinction coefficient of less than 0.0005 over the wavelength range of 800 nm to 1 100 nm.
Patent CA-2879631-A1 (CA)
Inventor: SWINFEN RICHARD
IPC: G07F19/00
Filed: 2013-07-23
Abstract: A method of controlling operation of a user terminal, wherein the user terminal comprises a controller for controlling operation of the user terminal, and the user terminal further comprises a plurality of devices, wherein in normal operation the controller is responsive to data received from at least one of the devices, and the method comprises providing, from a source other than said at least one of the devices, control data to the controller, the control data comprising data that the controller interprets as being received from said at least one the devices.
Patent CA-2880127-A1 (CA)
Title: Production of methane
Inventor: WOLFOWITZ STEVEN ALAN
IPC: C12M1/42
Filed: 2013-07-29
Abstract: This invention relates to a method for producing hydrocarbons from carbon dioxide and water in the presence of hydrogen and methanogen/s. the methanogen/s is/are provided in an aqueous growth substrate and the aqueous growth substrate is pressurized to a pressure of from 5 to 1000 bar with a pressurizing fluid containing or comprising carbon dioxide. In an embodiment of the invention, a cathode is provided to generate hydrogen and also to control the pH of the aqueous growth substrate. The invention also relates to an apparatus for carrying out the method.
Patent CA-2886012-A1 (CA)
Inventor: PESCOD CHRISTOPHER RALPH
IPC: G02B6/36
Filed: 2013-09-24
Abstract: A method and apparatus for operating an optical rotating joint (2); comprising: providing redundancy for camera sensor signals to be passed through an optical rotating joint (2) by:(i) passing signals from a plurality of camera sensors (28, 30) via an optical changeover switching arrangement (70) to the optical rotating joint (2); and/or (ii) passing signals for a plurality of camera sensors (28, 30) toward the camera sensors (28, 30) from the optical rotating joint (2) via an optical changeover switching arrangement (70).The signals may be sensor control signals or sensor output signals to/from a plurality of sensors (26, 28, 30), for example camera sensors. The apparatus may further comprise one or more wavelength division multiplexers (68, 94) and/or wavelength division demultiplexers (66, 95).
Patent CA-2886780-A1 (CA)
Title: Load handling by load handling device
Inventor: RINTANEN KARI
IPC: B66C13/46
Filed: 2013-10-02
Abstract: A load is handled by a load handling device comprising gripping means for gripping at least one fastening point of the load, comprising determining, in the gripping means, a distance map within the area of which are described a part of the area of the load to which the gripping means attach and/or on which another load is stacked, as well as surroundings of the load.
Patent CA-2887627-A1 (CA)
Title: Vetement integrant un systeme de collecte de donnees physiologiques
Inventor: FORT LAURENT
IPC: A61B5/00
Filed: 2013-10-07
Abstract: Système de collecte de données physiologiques (200) comprenant un équipement de collecte de données (270) comprenant au moins un module capteur (210) configuré pour capturer des mesures physiologiques, et un système de surveillance (220) configuré pour récupérer et transmettre les mesures physiologiques. L'équipement de collecte de données comprend un vêtement (205) dans lequel le module capteur et le système de surveillance sont intégrés. Le système de surveillance comprend au moins deux boîtiers (201, 202) se reliant mécaniquement de manière flexible pour se conformer à la forme d'une partie du corps, au moins un organe de liaison (211, 212) flexible pour relier mécaniquement les deux boîtiers, un module d'acquisition de données et de communication sans fil (222) installé dans un des deux boîtiers et un module de détection de mouvements (221) installé dans un des deux boîtiers.
Patent CA-2891493-A1 (CA)
Inventor: BACAC MARINA
IPC: C07K16/28
Filed: 2014-02-24
Abstract: The present disclosure generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present disclosure relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The disclosure further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.
Patent CA-2893601-A1 (CA)
Title: Heat treatment monitoring system
Inventor: STORK GENANNT WERSBORG INGO
IPC: F24C15/04
Filed: 2013-12-04
Abstract: A heat treatment monitoring system comprises a sensor unit having at least one sensor to determine current sensor data of food being heated; a processing unit to determine current feature data from the current sensor data; and a monitoring unit adapted to determine a current heating process state in a current heating process of the monitored food by comparing the current feature data with reference feature data of a reference heating process.
Patent CA-2898401-A1 (CA)
Inventor: JONES JAMES DEAN
IPC: F16K11/24
Filed: 2015-07-27
Abstract: A control valve may include a fluid inlet, a plurality of fluid outlets, and a plurality of magnets. One of the plurality of magnets controls fluid flow for each of one of the plurality of fluid outlets. One of the plurality of magnets controls fluid flow for the remaining of the plurality of magnets. When the magnet controlling fluid flow for the remaining of the plurality of magnets is energized, fluid flow is permitted to the remaining of the plurality of magnets. When the remaining of the plurality of magnets are energized, fluid flow is permitted to the respective plurality of fluid outlets.
Patent CA-2898416-A1 (CA)
Inventor: MORITA MASAHIKO
IPC: A61P13/12
Filed: 2014-01-21
Abstract: La présente invention concerne un agent élevant la concentration d'oxyde nitrique (NO) contenant du glutathion ou un sel de celui-ci en tant que substance active, un agent élevant la concentration de NO contenant du glutathione ou un sel de celui-ci en tant que substance active pour prévenir ou réduire des symptômes associés à une fonction de l'endothéolium vasculaire réduite ou stimuler la vasodilatation ou la circulation sanguine en élevant la concentration de NO, et un procédé pour élever la concentration de NO par absorption de glutathion ou d'un sel de celui-ci.
Patent CA-2899267-A1 (CA)
Inventor: LEENHOUTS ABRAHAM
IPC: A23D7/005
Filed: 2013-11-15
Abstract: L'invention porte sur un procédé pour la fabrication d'une émulsion d'eau dans l'huile, comprenant 10 à 85 % en poids d'huile liquide; 0,5 à 50 % en poids de poudre de matière grasse comprenant de la matière grasse solide; 10 à 85 % en poids d'une phase aqueuse; 0,005 à 5 % en poids de lécithine; et 0,01 à 5 % en poids de monoglycéride; comprenant les étapes consistant à : 1. utiliser une solution d'au maximum 5 % en poids de l'huile liquide, par rapport à la quantité totale d'huile liquide, comprenant au moins 50 % en poids de la lécithine dissoute, par rapport à la quantité totale de lécithine et au moins 50 % en poids du monoglycéride dissous, par rapport à la quantité totale de monoglycéride, la température de la solution étant d'au moins 50 degrés Celsius; 2. utiliser un système à phase continue huileuse comprenant au moins 75 % en poids de l'huile liquide, par rapport à la quantité totale de l'huile liquide, le système ayant une température de 0 à 20 degrés Celsius; 3. mettre en contact la solution obtenue dans l'étape 1 avec le système obtenu à l'étape 2; et 4. Mélanger le mélange obtenu à l'étape 3 pour obtenir une émulsion d'eau dans l'huile; tous les ingrédients restants étant ajoutés dans leur totalité à l'étape 2, l'étape 3 ou l'étape 4 ou ajoutés en partie en une quelconque association à l'étape 2, l'étape 3 et l'étape 4. Le procédé de l'invention permet d'obtenir des émulsions d'eau dans l'huile présentant une stabilité améliorée et une variation de stabilité réduite entre les lots.
Patent CA-2900308-A1 (CA)
Title: Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Inventor: GNAMM CHRISTIAN
IPC: A61P19/02
Filed: 2014-02-05
Abstract: This invention relates to substituted bicyclic dihydropyrimidinones of formula (I) and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.
Patent CA-2903585-A1 (CA)
Inventor: SMITH RAYMOND
IPC: B63C11/04
Filed: 2014-03-06
Abstract: A method of designing a material comprising the steps of defining one or more ocean locations and measuring or calculating reflectance spectra at said locations along one or more predefined viewing angles. From each reflectance spectra, a wavelength range located in or around a maximum region of said reflectance spectra is selected and a material is created by applying colours from each of the wavelength ranges to portions of the material surface.
Patent CA-2908482-A1 (CA)
Title: Novel compounds as dual inhibitors of phosphodiesterases and histone deacetylases
Inventor: CUADRADO TEJEDOR MARIA DEL MAR
IPC: A61K31/4412
Filed: 2014-02-27
Abstract: It relates to certain compounds having a polycyclic structure and a hydroxamic acid moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to a process for their preparation, as well as to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neurodegenerative diseases. wherein B1 is a radical selected from the group consisting of formula (A"), formula (B"), formula (C"), and formula (D"):
Patent CA-2910442-A1 (CA)
Inventor: SHIMA TOSHIHIKO
IPC: F16K17/30
Filed: 2015-10-27
Abstract: Un élément de vanne (12) dun détendeur de pression comprend une partie conique (23) siégeant sur une périphérie intérieure dun orifice de vanne (31). Lorifice (31) comprend une première zone (33), une deuxième zone (34) et une troisième zone (35), dans cet ordre à partir dun côté en amont. La première zone (33) est fournie, de sorte que lélément de vanne (12) soit ouvert, la hauteur dun passage définie entre la première zone (33) et la partie conique (23) étant graduellement réduite en aval. La deuxième zone (34) est fournie de sorte que la hauteur dun passage définie entre la deuxième zone (34) et la partie conique (23) soit constante lorsque lélément de vanne (12) est ouvert, et de sorte que toute la deuxième zone (34) soit en contact avec la partie conique (23) lorsque lélément de vanne (12) est fermé. La troisième zone (35) est fournie, de sorte que lélément de vanne (12) soit ouvert, la hauteur dun passage définie entre la troisième zone (35) et la partie conique (23) étant graduellement accrue en aval.
Patent CA-2910688-A1 (CA)
Inventor: WU HAIMING
IPC: A61M5/32
Filed: 2014-05-02
Abstract: A drug delivery device for injecting medicament, the device including a main body having a surface for contacting a patient, an actuation button (110, 420, 436) movably disposed relative to the main body, and a reservoir disposed within the main body for containing a medicament. The device also includes a needle having a distal end for insertion into a patient, and a lumen extending proximally from the distal end, wherein said lumen is fluidly connectable with the reservoir. The device further includes a removable needle cover (114, 400) for selectively covering the distal end of the needle and selectively preventing movement of the actuation button relative to the main body that initiates activation of the device.
Patent CA-2910704-A1 (CA)
Title: Custom die for supporting a machined object
Inventor: MIQUEL FLORENT
IPC: A61F2/02
Filed: 2013-06-27
Abstract: There is provided a device for supporting an object during machining thereof, the object having a first object surface having a patient-specific configuration and a second object surface opposite the first object surface. The device comprises a support member adapted to support the object, the support member having a support surface shaped using patient-specific modeling and configured to matingly engage at least a portion of the first object surface for exposing the second object surface for machining thereof.
Patent CA-2916673-A1 (CA)
Inventor: GANS ADAM
IPC: A43B5/16
Filed: 2016-01-05
Abstract: ABRÉGÉ : Il est décrit un porte-lame pour patins (un patin de hockey, par exemple). Le patin comprend une botte de patin conçue pour recevoir le pied de lutilisateur. Le porte-lame comprend une base de retenue de la lame servant à retenir une lame. La base de retenue de la lame se compose dun premier matériau (p. ex. une matière polymérique non composite). Le porte-lame comprend un élément de support qui sétend vers le haut à partir de la base de retenue de la lame afin dattacher le porte-lame et la botte du patin. Le support comprend un deuxième matériau (p. ex. un matériau composite) qui diffère du premier matériau par sa rigidité accrue. Date reçue/Date Received 2022-06-22
Patent CA-2917990-A1 (CA)
Title: Ampoule for a medical liquid, and method for producing an ampoule
Inventor: BRANDENBURGER TORSTEN
IPC: A61J1/06
Filed: 2014-07-15
Abstract: The invention relates to an ampoule (1) for a medical liquid, comprising an ampoule body (10) for receiving a medical liquid and a connection part (11) for connecting a removal device (2) to the ampoule (1). The ampoule body (10) is produced as a plastic injection-molded part by means of a plastic injection molding process. In this manner an ampoule is provided which allows a simple and inexpensive production of the ampoule and can ensure a sterile storage of medical liquids.
Patent CA-2919224-A1 (CA)
Inventor: MYLLYOJA JUKKA
IPC: C07C1/207
Filed: 2016-01-28
Abstract: The present invention relates to catalytic conversion of ketoacids, including methods for increasing the molecular weight of ketoacids, the method comprising the steps of providing in a reactor a raw material comprising at least one ketoacid. The raw material is then subjected to one or more C-C-coupling reaction(s) in the presence of an ion exchange resin catalyst to produce at least one ketocid dimer, the method further comprising providing steps of providing in a reactor a feedstock comprising the at least one ketoacid dimer and subjecting the feedstock to one or more C-C-coupling reaction(s) at a temperature of at least 200 °C.